In:
Journal of Pediatric Gastroenterology and Nutrition, Wiley, Vol. 78, No. 3 ( 2024-03), p. 699-703
Abstract:
The randomized double‐blind controlled trial PRESTO showed that infants receiving amino acid‐based formula (AAF) with or without synbiotics for 12 months in early life demonstrated effective symptom resolution. After 12 and 24 months, development of tolerance to cow's milk (CM) was in line with natural outgrowth. What is New This study shows that, 36 months after the start of the intervention, a high proportion of children (about three‐quarters) developed tolerance to CM. These data suggest that the consumption of AAF, with or without synbiotics, and the absence of exposure to CM peptides do not slow down CM tolerance acquisition.
Type of Medium:
Online Resource
ISSN:
0277-2116
,
1536-4801
Language:
English
Publisher:
Wiley
Publication Date:
2024
detail.hit.zdb_id:
2078835-6
Bookmarklink